The HIV Seroconversion StudyA clinical trial is a research study to answer specific questions about vaccines or new therapies or new ways of using known treatments. Clinical trials are used to determine whether new drugs or treatments are both safe and effective. Carefully conducted clinical trials are the fastest and safest way to find treatments that work in people. Trials are in four phases: Phase I tests a new drug or treatment in a small group; Phase II expands the study to a larger group of people; Phase III expands the study to an even larger group of people; and Phase IV takes place after the drug or treatment has been licensed and marketed. is a study of men who have been recently infected with HIV. It will provide valuable information for health promotion efforts and may be used in the development of health promotion materials for gay and other men who have sex with men.
Participants will be asked to complete an anonymous web-based survey which takes about 30 minutes. In the first part, participants are asked about details concerning sexual behaviour at the time of the event which they think might have led to their HIV infection. In the second part, participants are asked to recall sexual behaviour during the six-months prior to the high risk event testing HIV-positive.
Feedback about the results of the survey will be provided through the media, public meetings and seminars, and through reports and publications prepared by the Seroconversion Study team.
The survey is a project of NCHECRNational Centre in HIV Epidemiology and Clinical Research. Based at the University of NSW in Sydney, NCHECR is one of Australia's leading medical research centres and is recognised internationally as a leader in the field of research into HIV/AIDS and viral hepatitis. . If you have any questions, please email seroconversion@nchecr.unsw.edu.au or call Ian Down on 02 9385 0900
Do the survey.
This site complies with the HONcode standard for trustworthy health information: verify here. 
